转移性胃肠道 stromal 瘤中的苏尼蒂尼布诱导的高血性脑病变:一个病例报告
Takaoki Hayakawa1, Shinsuke Funakoshi2, Yasuo Hamamoto3
1Department of Internal Medicine, Division of Gastroenterology and Hepatology, Keio University School of Medicine, Shinjuku-ku 160-8582, Tokyo, Japan.
World journal of clinical cases
|December 11, 2023
概括
苏尼蒂尼布是一种铁氨酸激酶抑制剂 (TKI),可在胃肠道 stromal 瘤 (GIST) 患者中引起罕见但严重的高血性脑病变. 及时评估和治疗对于管理这种可能危及生命的TKI副作用至关重要.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 神经学 神经学
背景情况:
- 苏尼蒂尼布是一种多向的铁氨酸激酶抑制剂 (TKI),已被批准用于晚期胃肠道瘤 (GIST).
- 超氨性脑病变是一种罕见但严重的并发症,与sunitinib治疗有关.
- 本报告详细介绍了一例转移性GIST患者的病例,没有先前存在的肝硬化.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
167
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
167
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
208
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
208
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K


